Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

HIV-ASSIST: A New Tool to Guide Evidence-Based Selection of Antiretroviral Therapy
  • CME
  • MOC
  • CE

Credits Available
Physicians: maximum of 0.75 AMA PRA Category 1 Credits
US Physicians: maximum of 0.75 Medical Knowledge MOC point(s)
Registered Nurses: 0.75 Nursing contact hours
Pharmacists: 0.75 contact hours (0.075 CEUs)
Physician Assistants: maximum of 0.75 hours of AAPA Category I CME credits
Released: February 4, 2021 Expiration: February 3, 2022
Start Activity
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Produced in collaboration with
Educational grant provided by:
Gilead Sciences, Inc.
Theratechnologies Inc.
ViiV Healthcare
person default
Jonathan Li, MD
Maunank Shah, MD

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Describe data that validate the effectiveness of HIV-ASSIST as a clinical decision support tool
  • Formulate guideline-based first-line ART regimens for previously untreated patients, through appropriate use of HIV-ASSIST
  • Identify guideline-based ART regimens for patients with virologic failure, through appropriate use of HIV-ASSIST

Information on this Educational Activity

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Faculty

Maunank Shah, MD

Assistant Professor
Division of Infectious Diseases
Department of Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland

Maunank R. Shah, MD, PhD, has no relevant conflicts of interest to report.
Jonathan Li, MD

Assistant Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Brigham and Women's Hospital
Harvard Medical School
Boston, Massachusetts

Jonathan Z. Li, MD, MMSc, has disclosed that he has received consulting fees from AbbVie.

Staff

Edward King, MA

Executive Vice President

Edward King, MA, has no relevant conflicts of interest to report.
Jennifer Blanchette, PhD

Senior Scientific Director

Jennifer M. Blanchette, PhD, has no relevant conflicts of interest to report.
Jennifer Swanson, PharmD

Editorial Contributor

Jennifer Swanson, PharmD, has no relevant conflicts of interest to report.
Julie Skowronski, FNP-BC
Julie Skowronski, FNP-BC, has no relevant conflicts of interest to report.
Mark Christiansen, PhD, PA-C
Mark Christiansen, PhD, PA-C, has no relevant conflicts of interest to report.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for physicians, registered nurses, physician assistants, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.

Goal

The goal of this activity is to improve clinicians’ knowledge and competence in selecting optimal ART for persons with HIV by integrating HIV-ASSIST into their clinical decision-making.

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

Successful completion of this activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nursing Continuing Education

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Continuing Pharmacy Education

Credit Designation

CCO designates this continuing education activity for 0.75 contact hour (0.075 CEU) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-21-032-H02-P.

Type of Activity: Knowledge

Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Assistant Continuing Education

Credit Designation

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until February 3, 2022. PAs should only claim credit commensurate with the extent of their participation.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from February 04, 2021, through February 03, 2022:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Case 1: Initiating ART in a Treatment-Naive Patient
  • CME
  • MOC
  • CE

Loading...
Faculty demonstrate the use of HIV-ASSIST in choosing appropriate ART in a treatment-naive patient.
person default
Jonathan Li, MD
Maunank Shah, MD
Physicians: maximum of 0.75 AMA PRA Category 1 Credits
US Physicians: maximum of 0.75 Medical Knowledge MOC point(s)
Registered Nurses: 0.75 Nursing contact hours
Pharmacists: 0.75 contact hours (0.075 CEUs)
Physician Assistants: maximum of 0.75 hours of AAPA Category I CME credits
Released: February 4, 2021 Expiration: February 3, 2022

This program is divided into several short segments which you can step through using the Video Chapters menu.

Related Content

CCO commentary by Dr. Darcy Wooten on data presented at CROI 2021 regarding integrase strand inhibitor-associated weight gain and clinical implications

Darcy Wooten, MD Released: May 5, 2021

Short video log from Dr. Bisola Ojikutu on racial disparities and social determinants of health affecting care of aging patients with HIV from Clinical Care Options (CCO)

Bisola Ojikutu, MD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 29, 2021 Expired: April 28, 2022

Download free slides reviewing a patient case and key data on racial disparities and social determinants of health impacting older patients with HIV

Bisola Ojikutu, MD, MPH Released: April 29, 2021

Video Chapters


Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Produced in collaboration with
Educational grant provided by:
Gilead Sciences, Inc.
Theratechnologies Inc.
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue